Efficacy and Safety of Nivolumab in Asian Patients (Pts) With Advanced Hepatocellular Carcinoma (HCC): Subanalysis of the CheckMate 040 Study

被引：0

作者：

Kudo, Masatoshi ^{[1
]}

Hsu, Chiun ^{[2
,3
]}

Kim, Tae-You ^{[4
]}

Choo, Su-Pin ^{[5
]}

Kang, Yoon-Koo ^{[6
]}

Hou, Ming-Mo ^{[7
]}

Yeo, Winnie ^{[8
]}

Numata, Kazushi ^{[9
]}

Chopra, Akhil ^{[10
]}

Baakili, Adyb ^{[11
]}

dela Cruz, Christine ^{[11
]}

Zhao, Huanyu ^{[11
]}

Yau, Thomas ^{[12
]}

机构：

[1] Kindai Univ, Fac Med, Osaka, Japan

[2] Natl Taiwan Univ Hosp, Taipei, Taiwan

[3] Natl Taiwan Univ, Ctr Canc, Taipei, Taiwan

[4] Seoul Natl Univ Hosp, Seoul, South Korea

[5] Natl Canc Ctr, Singapore, Singapore

[6] Univ Ulsan, Asan Med Ctr, Seoul, South Korea

[7] Chang Gung Mem Hosp, Taipei, Taiwan

[8] Chinese Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China

[9] Yokohama City Univ, Med Ctr, Yokohama, Kanagawa, Japan

[10] Johns Hopkins Singapore Int Med Ctr, Singapore, Singapore

[11] Bristol Myers Squibb, Princeton, NJ USA

[12] Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

O2-14-1

引用

页数：1